Voloridge Investment Management’s BioXcel Therapeutics BTAI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,160	Closed	-$645K	–	1369
2023 Q1	$645K	Buy	+2,160	New	+$645K	﹤0.01%	1191
2022 Q4	–	Sell	-5,562	Closed	-$1.05M	–	1446
2022 Q3	$1.05M	Sell	5,562 -826	-13%	-$156K	0.01%	1148
2022 Q2	$1.35M	Buy	+6,388	New	+$1.35M	0.01%	1121